201 related articles for article (PubMed ID: 11771957)
1. Association between IA-2 autoantibody epitope specificities and age of onset in Japanese patients with autoimmune diabetes.
Kawasaki E; Sera Y; Fujita N; Yamauchi M; Ozaki M; Abe T; Yamakawa K; Uotani S; Takino H; Yamasaki H; Yamaguchi Y; Uchigata Y; Matsuura N; Eguchi K
J Autoimmun; 2001 Dec; 17(4):323-31. PubMed ID: 11771957
[TBL] [Abstract][Full Text] [Related]
2. Distinct IA-2 autoantibody epitope recognition between childhood-onset and adult-onset type 1 diabetes.
Kawasaki E; Sera Y; Abiru N; Yamauchi M; Ozaki M; Yamakawa K; Abe T; Uotani S; Yamasaki H; Yamaguchi Y; Eguchi K
Ann N Y Acad Sci; 2002 Apr; 958():235-40. PubMed ID: 12021114
[TBL] [Abstract][Full Text] [Related]
3. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
Bonifacio E; Lampasona V; Bingley PJ
J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
[TBL] [Abstract][Full Text] [Related]
4. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
Naserke HE; Ziegler AG; Lampasona V; Bonifacio E
J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen.
Lampasona V; Bearzatto M; Genovese S; Bosi E; Ferrari M; Bonifacio E
J Immunol; 1996 Sep; 157(6):2707-11. PubMed ID: 8805677
[TBL] [Abstract][Full Text] [Related]
6. IA-2 antibody epitopes and isotypes during the prediabetic process in siblings of children with type 1 diabetes.
Hoppu S; Härkönen T; Ronkainen MS; Akerblom HK; Knip M;
J Autoimmun; 2004 Dec; 23(4):361-70. PubMed ID: 15571930
[TBL] [Abstract][Full Text] [Related]
7. Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.
Tiberti C; Giordano C; Locatelli M; Bosi E; Bottazzo GF; Buzzetti R; Cucinotta D; Galluzzo A; Falorni A; Dotta F
Diabetes; 2008 May; 57(5):1276-83. PubMed ID: 18332100
[TBL] [Abstract][Full Text] [Related]
8. Radiobinding assay for detecting autoantibodies to single epitopes.
Lampasona V; Belloni C; Piquer S; Bonicchio S; Furlan R; Bonifacio E
J Immunol Methods; 2008 Jul; 336(2):127-34. PubMed ID: 18501377
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterisation of a human monoclonal autoantibody to the islet cell autoantigen IA-2.
Ananieva-Jordanova R; Evans M; Nakamatsu T; Premawardhana LD; Sanders J; Powell M; Chen S; McGrath V; Belton C; Arnold C; Baker S; Betterle C; Zanchetta R; Smith BR; Furmaniak J
J Autoimmun; 2005 Jun; 24(4):337-45. PubMed ID: 15869863
[TBL] [Abstract][Full Text] [Related]
10. Antigenic determinants to GAD autoantibodies in patients with type 1 diabetes with and without autoimmune thyroid disease.
Park H; Yu L; Kim T; Cho B; Kang J; Park Y
Ann N Y Acad Sci; 2006 Oct; 1079():213-9. PubMed ID: 17130557
[TBL] [Abstract][Full Text] [Related]
11. Recombinant IA-2 expressed in E. coli can be used for the routine detection of autoantibodies in Type-I diabetes.
Morgenthaler NG; Löbner K; Morgenthaler UY; Christie MR; Seissler J; Scherbaum WA
Horm Metab Res; 1998 Sep; 30(9):559-64. PubMed ID: 9808324
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody 76F distinguishes IA-2 from IA-2beta and overlaps an autoantibody epitope.
Piquer S; Valera L; Lampasona V; Jardin-Watelet B; Roche S; Granier C; Roquet F; Christie MR; Giordano T; Malosio ML; Bonifacio E; Laune D
J Autoimmun; 2006 May; 26(3):215-22. PubMed ID: 16503116
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to IA-2 in type 1 diabetes: measurements with a new enzyme-linked immunosorbent assay.
Kawasaki E; Yamaguchi H; Hattori H; Egashira T; Eguchi K
Ann N Y Acad Sci; 2002 Apr; 958():241-6. PubMed ID: 12021115
[TBL] [Abstract][Full Text] [Related]
14. ICA512(IA-2) epitope specific assays distinguish transient from diabetes associated autoantibodies.
Miao D; Yu L; Tiberti C; Cuthbertson DD; Rewers M; di Mario U; Eisenbarth GS; Dotta F
J Autoimmun; 2002 Mar; 18(2):191-6. PubMed ID: 11908951
[TBL] [Abstract][Full Text] [Related]
15. Influence of HLA-DR and -DQ alleles on autoantibody recognition of distinct epitopes within the juxtamembrane domain of the IA-2 autoantigen in type 1 diabetes.
Richardson CC; McLaughlin KA; Morgan D; Feltbower RG; Christie MR
Diabetologia; 2016 Feb; 59(2):334-40. PubMed ID: 26564179
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
[TBL] [Abstract][Full Text] [Related]
17. IA-2 autoantibodies predict impending type I diabetes in siblings of patients.
Decochez K; De Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Weets I; Vandemeulebroucke E; Truyen I; Kaufman L; Schuit FC; Pipeleers DG; Gorus FK;
Diabetologia; 2002 Dec; 45(12):1658-66. PubMed ID: 12488955
[TBL] [Abstract][Full Text] [Related]
18. GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes.
Mayr A; Schlosser M; Grober N; Kenk H; Ziegler AG; Bonifacio E; Achenbach P
Diabetes; 2007 Jun; 56(6):1527-33. PubMed ID: 17325256
[TBL] [Abstract][Full Text] [Related]
19. Humoral immune response to islet autoantigens in Japanese patients with type 1 diabetes.
Kawasaki E; Kuriya G; Satoh T; Fujishima K; Moriuchi A; Fukushima K; Ozaki M; Abiru N; Yamasaki H; Eguchi K
Ann N Y Acad Sci; 2008 Dec; 1150():248-51. PubMed ID: 19120305
[TBL] [Abstract][Full Text] [Related]
20. Humoral autoimmune responses to glutamic acid decarboxylase have similar target epitopes and subclass that show titer-dependent disease association.
Piquer S; Belloni C; Lampasona V; Bazzigaluppi E; Vianello M; Giometto B; Bosi E; Bottazzo GF; Bonifacio E
Clin Immunol; 2005 Oct; 117(1):31-5. PubMed ID: 16027042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
